Psychoactive polytherapy combining an antipsychotic with an antidepressant or lithium significantly increased the mean QTc interval by 24 ms compared to a 1 ms decrease with antipsychotic monotherapy.
Observational (n=38)
Single-blind (outcome assessor)
No
Does psychoactive polytherapy increase QTc interval compared to antipsychotic monotherapy in hospitalized women with psychiatric disorders?
Combining antipsychotics with antidepressants or lithium significantly increases the QTc interval compared to antipsychotic monotherapy, highlighting the need for careful ECG monitoring.
Absolute Event Rate: 24% vs -1%
p-value: p=<0.01
BACKGROUND: Several antipsychotic agents are known to prolong the QT interval in a dose dependent manner. Corrected QT interval (QTc) exceeding a threshold value of 450 ms may be associated with an increased risk of life threatening arrhythmias. Antipsychotic agents are often given in combination with other psychotropic drugs, such as antidepressants, that may also contribute to QT prolongation. This observational study compares the effects observed on QT interval between antipsychotic monotherapy and psychoactive polytherapy, which included an additional antidepressant or lithium treatment. METHOD: We examined two groups of hospitalized women with Schizophrenia, Bipolar Disorder and Schizoaffective Disorder in a naturalistic setting. Group 1 was composed of nineteen hospitalized women treated with antipsychotic monotherapy (either haloperidol, olanzapine, risperidone or clozapine) and Group 2 was composed of nineteen hospitalized women treated with an antipsychotic (either haloperidol, olanzapine, risperidone or quetiapine) with an additional antidepressant (citalopram, escitalopram, sertraline, paroxetine, fluvoxamine, mirtazapine, venlafaxine or clomipramine) or lithium. An Electrocardiogram (ECG) was carried out before the beginning of the treatment for both groups and at a second time after four days of therapy at full dosage, when blood was also drawn for determination of serum levels of the antipsychotic.Statistical analysis included repeated measures ANOVA, Fisher Exact Test and Indipendent T Test. RESULTS: Mean QTc intervals significantly increased in Group 2 (24 +/- 21 ms) however this was not the case in Group 1 (-1 +/- 30 ms) (Repeated measures ANOVA p < 0,01). Furthermore we found a significant difference in the number of patients who exceeded the threshold of borderline QTc interval value (450 ms) between the two groups, with seven patients in Group 2 (38%) compared to one patient in Group 1 (7%) (Fisher Exact Text, p < 0,05). CONCLUSIONS: No significant prolongation of the QT interval was found following monotherapy with an antipsychotic agent, while combination of these drugs with antidepressants caused a significant QT prolongation. Careful monitoring of the QT interval is suggested in patients taking a combined treatment of antipsychotic and antidepressant agents.
Sala et al. (Tue,) conducted a observational in Schizophrenia, Bipolar Disorder, and Schizoaffective Disorder (n=38). Psychoactive polytherapy (antipsychotic plus antidepressant or lithium) vs. Antipsychotic monotherapy was evaluated on Mean QTc interval change from baseline (p=<0.01). Psychoactive polytherapy combining an antipsychotic with an antidepressant or lithium significantly increased the mean QTc interval by 24 ms compared to a 1 ms decrease with antipsychotic monotherapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: